Healthcare - Biotechnology - NASDAQ - US
$ 0.8599
-4.32 %
$ 77.3 M
Market Cap
-0.91
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
405.07%
EBIT
Estimate
--22.69%
Net Income
Estimate
27.62%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Chimerix, Inc.
CMRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CMRX
EBIT FORECAST
EBIT Forecast Chart CMRX
NET INCOME FORECAST
Net Income Chart CMRX